comparemela.com
Home
Live Updates
Alembic Pharmaceuticals receives USFDA Final Approval for Doxycycline Hyclate Delayed-Release Tablets : comparemela.com
Alembic Pharmaceuticals receives USFDA Final Approval for Doxycycline Hyclate Delayed-Release Tablets
Alembic Pharmaceuticals Limited today announced that it has received final approval from the USFDA for its ANDA for Doxycycline Hyclate Delayed-Release Tablets USP, 75 mg, 100 mg, 150 mg, and 200 mg.
Related Keywords
,
Alembic Pharmaceuticals Limited ,
Alembic Pharmaceuticals ,
Us Food Drug Administration ,
Mayne Pharma International Pty ,
Pharmaceuticals Limited ,
Drug Administration ,
Abbreviated New Drug Application ,
Doxycycline Hyclate Delayed Release Tablets ,
Doryx Tablets ,
Mayne Pharma International ,
Doxycycline Hyclate Delayedrelease Tablets ,
Alembicpharmaceuticals ,
Ine901l01018 ,
Usfda ,
Panda ,
Finalapproval ,
Doxycyclinehyclate ,
Delayedreleasetablets ,
comparemela.com © 2020. All Rights Reserved.